Position in BHC
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$426,321
+$166,522 QoQ
Shares Held
86,475
+79.7% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 220 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $41,885,898 across 15 Drug Manufacturers - Specialty & Generic names. BHC ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
237,003 | $17,031,034 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
470,178 | $15,929,630 | |
| 3 | LQDA |
Liquidia Corp
|
60,962 | $4,860,500 | |
| 4 | ALKS |
Alkermes plc.
|
22,074 | $1,156,677 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,857 | $481,518 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
12,421 | $430,636 | |
| 7 | BHC |
Bausch Health Companies Inc.
This page
|
86,475 | $426,321 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
761 | $412,330 |
All Filings in BHC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $426,321 | 86,475 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $259,799 | 48,111 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $164,165 | 23,621 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $182,960 | 28,366 | Shares | Defined | 2025-10-15 | |
| 2021-09-30 | $264,267 | 9,489 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $304,429 | 10,383 | Shares | Defined | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||